Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia
- PMID: 9829897
- DOI: 10.1002/(sici)1097-0304(199811)45:3<318::aid-ccd23>3.0.co;2-2
Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia
Abstract
Heparin is considered necessary during percutaneous coronary interventions; however, heparin is contraindicated in patients with heparin-induced thrombocytopenia and/or heparin antibodies. We describe the successful use of the heparinoid Orgaran (danaparoid sodium) in addition to abciximab (ReoPro) in a patient with heparin antibodies who required rotational atherectomy.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
